Terminated PHASE3 INTERVENTIONAL 2-arm NCT01093963

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Adjunctive Lisdexamfetamine in Bipolar Depression

Sponsor: Lindner Center of HOPE

Updated 5 times since 2017 Last updated: Aug 31, 2015 Started: Jan 31, 2010 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrollment goals not met

Other terminated trials from Lindner Center of HOPE

See all terminations from Lindner Center of HOPE

Other Bipolar Depression trials with similar outcome

Browse all Bipolar Depression trials

A PHASE3 clinical study on Bipolar Depression, this trial is terminated or withdrawn. The trial is conducted by Lindner Center of HOPE and has accumulated 5 data snapshots since 2010. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lindner Center of HOPE
Shire
University of Cincinnati

Data source: Lindner Center of HOPE

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mason, United States